Phase 3 Hemophilia A Clinical Trials
11 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–11 of 11 trials
Recruiting
Phase 3
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Hemophilia AHemophilia B
Pfizer173 enrolled17 locationsNCT05568719
Recruiting
Phase 3
SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Hemophilia A
Emory University5 enrolled2 locationsNCT04563520
Recruiting
Phase 3
Safety of KN057 Prophylaxis in Patients With Haemophilia A or B
Hemophilia A or B
Suzhou Alphamab Co., Ltd.70 enrolled1 locationNCT07545395
Recruiting
Phase 3
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Hemophilia AHemophilia B
Pfizer245 enrolled75 locationsNCT05145127
Recruiting
Phase 3
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Hemophilia A
Hoffmann-La Roche126 enrolled2 locationsNCT07416526
Recruiting
Phase 3
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Hemophilia A
Hoffmann-La Roche360 enrolled3 locationsNCT07416604
Recruiting
Phase 3
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Hemophilia AHemophilia B
Pfizer100 enrolled66 locationsNCT05611801
Recruiting
Phase 2Phase 3
Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs
Hemophilia A
Shanghai Xinzhi BioMed Co., Ltd.55 enrolled10 locationsNCT06111638
Recruiting
Phase 3
Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products
Congenital Hemophilia A
CSL Behring60 enrolled20 locationsNCT06738485
Recruiting
Phase 3
To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A
Hemophilia A
Gritgen Therapeutics Co., Ltd.50 enrolled13 locationsNCT06833983
Recruiting
Phase 3
Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein
Severe Hemophilia A
Jiangsu Gensciences lnc.120 enrolled28 locationsNCT06142552